Clearlake to buy majority stake in Modernizing Medicine that values it at $5.3 billion, FT reports

Private equity group Clearlake Capital is close to a deal to buy a majority stake in Modernizing Medicine (ModMed) that could value the medical software provider at $5.3 billion including debt, the Financial Times reported on Sunday.